HGH — Heartland group Income Statement
0.000.00%
Last trade - 00:00
- NZ$801.61m
- NZ$3.15bn
- NZ$301.87m
- 18
- 92
- 35
- 49
C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 194 | 217 | 234 | 250 | 282 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 174 | 187 | 219 | 236 | 259 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 102 | 99.1 | 119 | 137 | 134 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.6 | 72 | 87 | 95.1 | 95.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 73.6 | 72 | 87 | 95.1 | 95.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 73.6 | 72 | 87 | 95.1 | 95.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.13 | 0.124 | 0.148 | 0.16 | 0.139 |
Dividends per Share | |||||
Special Dividends per Share |